Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer

Urology

Volumn 67, Issue 2, 2006, Pages 349-353

  Rossi, Peter J ^a   Clark, Peter E ^a   Papagikos, Michael A ^a   McCullough, David L ^a   Lee, W Robert ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HUMAN; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

AGED; AGED, 80 AND OVER; BIOPSY; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 31944436965     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.08.047     Document Type: Article

References (22)

1. A. Jemal, T. Murray, E. Ward Cancer statistics, 2005 CA Cancer J Clin 55 2005 10 30
2. M.R. Cooperberg, D.P. Lubeck, M.V. Meng The changing face of low-risk prostate cancer trends in clinical presentation and primary management J Clin Oncol 22 2004 2141 2149
3. C.J. Mettlin, G.P. Murphy, C.J. McDonald The National Cancer Database Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S Cancer 86 1999 1877 1882
4. A.V. D'Amico, R. Whittington, S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
5. A.V. D'Amico, R. Whittington, S.B. Malkowicz Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer J Clin Oncol 18 2000 1164 1172
6. A.V. D'Amico, D. Schultz, B. Silver The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 49 2001 679 684
7. G.S. Merrick, W.M. Butler, R.W. Galbreath Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland Int J Radiat Oncol Biol Phys 52 2002 664 673
8. American Joint Committee on Cancer AJCC Cancer Staging Manual 6th ed. 2002 Springer New York
9. L.A. Eskew, R.L. Bare, D.L. McCullough Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate J Urol 157 1997 199 202
10. J.C. Blasko, T. Mate, J.E. Sylvester Brachytherapy for carcinoma of the prostate techniques, patient selection, and clinical outcomes Semin Radiat Oncol 12 2002 81 94
11. P.D. Grimm, J.C. Blasko, H. Ragde Does brachytherapy have a role in the treatment of prostate cancer? Hematol Oncol Clin North Am 10 1996 653 673
12. S. Nag, W. Bice, K. DeWyngaert The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis Int J Radiat Oncol Biol Phys 46 2000 221 230
13. American Society for Therapeutic Radiology and Oncology Consensus Panel Consensus statement guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1997 1035 1041
14. D.I. Quinn, S.M. Henshall, P.C. Brenner Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion Cancer 97 2003 1884 1893
15. T.J. Sebo, J.C. Cheville, D.L. Riehle Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen a report of 454 cases Cancer 91 2001 2196 2204
16. S.J. Freedland, W.J. Aronson, M.K. Terris Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy results from SEARCH database J Urol 169 2003 2136 2141
17. W.W. Wong, S.E. Schild, S.A. Vora Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 60 2004 24 29
18. L.L. Kestin, N.S. Goldstein, F.A. Vicini Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy J Urol 168 2002 1994 1999
19. G.S. Merrick, W.M. Butler, R.W. Galbreath Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland Int J Radiat Oncol Biol Phys 52 2002 664 673
20. A.V. D'Amico, A.A. Renshaw, K. Cote Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease J Clin Oncol 22 2004 3726 3732
21. B.R. Prestidge, D.C. Hoak, P.D. Grimm Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer Int J Radiat Oncol Biol Phys 37 1997 31 39
22. N.N. Stone, R.G. Stock, P. Unger Biopsy results after real-time ultrasound-guided transperineal implants for stage T1-T2 prostate cancer J Endourol 14 2000 375 380